Trial intelligence / Profile preview

PDRN vs Dextrose for Lateral Epicondylitis

NCT02492945Phase 4Completed

Sponsor
Seoul National University Bundang Hospital
Start
Jun 2015
Primary completion
Sep 2016
Modality
Implantable Devices, Transdermal Patches, Inhalation Devices
Countries
1
01

Overview

A Phase 4 trial of rejuveinix in Lateral Epicondylitis (LET), sponsored by Seoul National University Bundang Hospital. Started Jun 2015; status: completed.

02

Drugs

rejuveinix
03

Conditions

Lateral Epicondylitis (LET)

Beyond the preview

Go deeper on NCT02492945.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02492945.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call